Evidence map›Paper›PMID 36534424›Full record

ReviewPathologica2022

Expanding the spectrum of "mesenchymal" tumors of the central nervous system.

Cristina Pizzimenti, Francesca Gianno, Marco Gessi

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pathologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Introduction.Pathologica · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Cristina PizzimentiDepartment of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, Italy.
Francesca GiannoDepartment of Radiological, Oncological and Pathological sciences, University of Rome "la Sapienza" Rome Italy.
Marco GessiNeuropathology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITSapienza University of Rome · ITUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this review, we summarize the clinical, histopathological, and molecular features of central nervous system (CNS) tumors with

Indexed as

Brain NeoplasmsCentral Nervous System NeoplasmsNeoplasms, Connective and Soft TissueSarcomaBiomarkers, TumorCentral Nervous SystemDEAD-box RNA HelicasesHumansProto-Oncogene ProteinsRepressor ProteinsRibonuclease IIIBiomarkers, TumorDEAD-box RNA HelicasesDICER1 protein, humanProto-Oncogene ProteinsRepressor ProteinsRibonuclease IIIcentral nervous systemCNSCNS tumor with BCOR internal tandem duplicationintracranial mesenchymal tumor withprimary intracranial sarcoma

Identifiers

PMID36534424
PMCPMC9763981
OpenAlexW4312047856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.